Pembrolizumab demonstrated clinical activity in patients with mycosis fungoides (MF) and Sézary syndrome (SS), the most common subtypes of cutaneous T-cell lymphoma (CTCL), with nearly half of ...

The results from the Phase 2 in CTCL in Sezary syndrome and mycosis fungoides were presented at ASH 2023 and ASCO 2024 and have been highly encouraging, showing that lacutamab has the potential to ...

for the treatment of hyperphagia in adults and children 4 years of age and older with Prader-Willi syndrome (PWS). Soleno expects VYKAT XR to be available in the U.S. beginning in April 2025.

Bubble-loving Elizabeth is one of the children to feature in the exhibition A new exhibition at a shopping centre is celebrating the "joy" of children with Down's syndrome, its creator says.